Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.

Mizusawa M, Perlman DC, Lucido D, Salomon N.

Int J STD AIDS. 2014 Mar;25(3):201-6. doi: 10.1177/0956462413495820. Epub 2013 Aug 29.

2.

Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.

Potsch DV, Camacho LA, Tuboi S, Villar LM, Miguel JC, Ginuíno C, Silva EF, Mendonça RM, Moreira RB, Barroso PF.

Vaccine. 2012 Sep 7;30(41):5973-7. doi: 10.1016/j.vaccine.2012.07.028. Epub 2012 Jul 21.

PMID:
22828589
3.

Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.

Bailey CL, Smith V, Sands M.

Int J Infect Dis. 2008 Nov;12(6):e77-83. doi: 10.1016/j.ijid.2008.05.1226. Epub 2008 Aug 23.

4.

HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.

O'Bryan TA, Rini EA, Okulicz J, Messner O, Ganesan A, Lalani T, Bavaro MF, O'Connell RJ, Agan BK, Landrum ML.

HIV Med. 2015 Mar;16(3):161-7. doi: 10.1111/hiv.12189. Epub 2015 Jan 14.

5.

Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?

Ni JD, Xiong YZ, Wang XJ, Xiu LC.

Int J STD AIDS. 2013 Feb;24(2):117-22. doi: 10.1177/0956462412472309. Epub 2013 May 6. Review.

PMID:
23467291
6.

Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.

Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C.

J Infect Dis. 2005 May 1;191(9):1435-41. Epub 2005 Mar 28.

PMID:
15809901
7.

Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.

Nicolini LA, Magne F, Signori A, Di Biagio A, Sticchi L, Paganino C, Durando P, Viscoli C.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):922-928. doi: 10.1089/AID.2017.0070. Epub 2018 Aug 16.

PMID:
29926738
8.

Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.

Chonwattana W, Raengsakulrach B, Holtz TH, Wasinrapee P, Tongtoyai J, Chaikummao S, Pattanasin S, McNicholl JM, van Griensven F, Curlin ME.

Vaccine. 2016 Apr 12;34(17):2044-50. doi: 10.1016/j.vaccine.2015.11.071. Epub 2015 Dec 10.

PMID:
26685092
9.

Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.

Lao-Araya M, Puthanakit T, Aurpibul L, Taecharoenkul S, Sirisanthana T, Sirisanthana V.

Vaccine. 2011 May 23;29(23):3977-81. doi: 10.1016/j.vaccine.2011.03.077. Epub 2011 Apr 5.

PMID:
21473954
11.

Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.

Kaech C, Pache I, Bürgisser P, Elzi L, Darling KE, Cavassini M.

J Infect. 2012 Aug;65(2):157-64. doi: 10.1016/j.jinf.2012.03.009. Epub 2012 Mar 9.

PMID:
22410383
12.

Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.

Morsica G, Bagaglio S, Spagnuolo V, Castagna A, Di Serio C, Galli A, Della Torre L, Andolina A, Pramov A, Uberti-Foppa C.

PLoS One. 2017 Sep 1;12(9):e0184128. doi: 10.1371/journal.pone.0184128. eCollection 2017.

13.

Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.

Irungu E, Mugo N, Ngure K, Njuguna R, Celum C, Farquhar C, Dhanireddy S, Baeten JM.

J Infect Dis. 2013 Feb 1;207(3):402-10. doi: 10.1093/infdis/jis695. Epub 2012 Nov 21.

14.

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.

Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.

Vaccine. 2012 Jun 8;30(27):4034-9. doi: 10.1016/j.vaccine.2012.04.031. Epub 2012 Apr 22.

PMID:
22531558
15.

Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil.

Martins S, Livramento Ad, Andrigueti M, Kretzer IF, Machado MJ, Spada C, Treitinger A.

Braz J Infect Dis. 2015 Mar-Apr;19(2):181-6. doi: 10.1016/j.bjid.2014.12.002. Epub 2015 Jan 24.

16.

The recombinant hepatitis B surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection?

Powis JE, Raboud J, Ostrowski M, Loutfy MR, Kovacs C, Walmsley SL.

J Infect Dis. 2012 May 15;205(10):1534-8. doi: 10.1093/infdis/jis243. Epub 2012 Mar 23.

PMID:
22448009
17.

Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.

Thaithumyanon P, Punnahitananda S, Praisuwanna P, Thisyakorn U, Ruxrungtham K.

J Med Assoc Thai. 2002 Mar;85(3):277-82.

PMID:
12117014
18.

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.

PMID:
18756185
19.

[Efficacy of vaccination against hepatitis B in adult with HIV infection].

Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T.

Przegl Epidemiol. 2007;61(2):339-47. Polish.

PMID:
17956052
20.

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load.

Rey D, Krantz V, Partisani M, Schmitt MP, Meyer P, Libbrecht E, Wendling MJ, Vetter D, Nicolle M, Kempf-Durepaire G, Lang JM.

Vaccine. 2000 Jan 18;18(13):1161-5.

PMID:
10649616

Supplemental Content

Support Center